By the same authors

From the same journal

From the same journal

Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

Research output: Contribution to journalArticlepeer-review

Published copy (DOI)



Publication details

JournalNew Genetics and Society
DatePublished - Jun 2008
Issue number2
Number of pages17
Pages (from-to)127-143
Original languageEnglish


The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented "regime of hope". This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a "promissory bioeconomy".

    Research areas

  • stem cells, cord blood banking, expectations, bioeconomy, TRANSPLANTATION

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations